D-Penicillamine , 10mMinWater , 52-67-5
Synonym(s):
D- (−)-2-Amino-3-mercapto-3-methylbutanoic acid;D -Penicillamine;3,3-Dimethyl-D -cysteine;3-Mercapto-D -valine
CAS NO.:52-67-5
Empirical Formula: C5H11NO2S
Molecular Weight: 149.21
MDL number: MFCD00064302
EINECS: 200-148-8
Pack Size | Price | Stock | Quantity |
1ml | RMB159.20 | In Stock |
|
others | Enquire |
PRODUCT Properties
Melting point: | 210 °C (dec.)(lit.) |
Boiling point: | 251.8±35.0 °C(Predicted) |
alpha | -65 º (c=5, 1M NaOH, on dry) |
Density | 1.113 (estimate) |
refractive index | -63 ° (C=1, 1mol/L NaOH) |
storage temp. | 2-8°C |
solubility | H2O: soluble100mg/mL |
form | Powder |
pka | pKa 7.83±0.01(H2O,t =37±0.05,I=0.15)(Approximate) |
color | White to almost white |
optical activity | -6325 (pyridine), L-form: +6325 (1 mol dm-3 NaOH) |
Water Solubility | 11.1 g/100 mL (20 ºC) |
Merck | 14,7088 |
BRN | 1722375 |
BCS Class | 3 |
Stability: | Stable. Incompatible with strong oxidizing agents. |
InChIKey | VVNCNSJFMMFHPL-VKHMYHEASA-N |
CAS DataBase Reference | 52-67-5(CAS DataBase Reference) |
NIST Chemistry Reference | Penicillamine(52-67-5) |
EPA Substance Registry System | Penicillamine (52-67-5) |
Description and Uses
Penicillamine is an orally bioavailable copper chelator and penicillin degradation product. It increases urinary and fecal copper excretion and decreases liver copper concentration in a rat model of copper overload when administered at 0.67 mmol/kg per day, but does not affect kidney, spleen, or brain copper levels. Penicillamine (100 mg/kg per day) dissolves copper-rich granules in hepatic lysosomes of Long-Evans cinnamon (LEC) rats, which spontaneously develop hepatic injury and acute hepatitis and have a mutation homologous to that of the human Wilson disease gene. Penicillamine has anticonvulsant and proconvulsant effects in mice when administered at 0.5 and 250 mg/kg, respectively, which are blocked by the nitric oxide synthase (NOS) inhibitors L-NAME and 7-nitroindazole . Formulations containing penicillamine have been used to treat Wilson disease, cystinuria, and active rheumatoid arthritis.
chelating agent (Cu), antirheumatic
Safety
Symbol(GHS) | GHS08 |
Signal word | Warning |
Hazard statements | H361d |
Precautionary statements | P201-P202-P280-P308+P313-P405-P501 |
Hazard Codes | Xi,T,Xn |
Risk Statements | 36/37/38-40-20/21/22 |
Safety Statements | 26-36-24/25-22 |
WGK Germany | 2 |
RTECS | YV9425000 |
Hazard Note | Toxic |
HS Code | 29309016 |
Hazardous Substances Data | 52-67-5(Hazardous Substances Data) |
Toxicity | LD50 in rats (mg/kg): >10000 orally, >660 i.p. (Jaffe) |